Clinical trials · Texas
Hemorrhage clinical trials in Texas
We’re tracking 29 recruiting hemorrhage studies with a site in Texas — including Early Phase 1, Phase 1, Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Texas
- NCT07294118RecruitingPhase 2
Lidocaine and steroids for pain after brain bleed
This trial tests whether giving a numbing medicine (lidocaine) and steroids into the artery that covers the brain can help reduce pain after a brain bleed. It may be an option for people with a specific type of bleeding who have not had certain brain surgeries or procedures.
Galveston, TexasAges 18–100 - NCT07227246RecruitingPhase 3
Testing rFVIIa for bleeding stroke within 2 hours
This trial tests whether a drug called Recombinant Factor VIIa (rFVIIa) can safely help stop bleeding in the brain during a hemorrhagic stroke. The goal is to give the drug as quickly as possible, within 2 hours of stroke onset, to see if it improves outcomes.
Houston, TexasAges 18–80 - NCT06994949RecruitingPhase 1
CSF flow study for babies with hemorrhagic hydrocephalus
This trial looks at how fluid moves in the brain of premature babies with hydrocephalus after bleeding. It uses special imaging to see if the fluid is flowing properly, which could help guide treatment.
Houston, TexasAges Up to 6 months - NCT06999122Recruiting
Testing a new helmet-style brain scanner for stroke bleeding
This trial tests a new type of brain scanner (similar to a helmet) that looks for bleeding in the brain without radiation. It is for people who have had stroke-like symptoms in the last 24 hours and have not yet received treatment.
Houston, TexasAges 22 years+ - NCT06799013RecruitingPhase 1
Testing a new RNA vaccine for Crimean-Congo hemorrhagic fever
This trial is testing an investigational RNA vaccine to see if it is safe and helps your body build immunity against Crimean-Congo hemorrhagic fever, a serious viral disease. The study involves two injections and follow-up visits over several months.
San Antonio, TexasAges 18–64 - NCT06797752Recruiting
Stellate ganglion block and retina blood flow study
This trial looks at how a nerve block (stellate ganglion block) affects blood flow in the retina. It may help people who already get this block for conditions like complex regional pain syndrome understand eye effects.
Dallas, TexasAges 18 years+ - NCT06742801Recruiting
Onyx liquid embolic for active bleeding outside the brain and heart
This trial tests a liquid material called Onyx that is injected into blood vessels to stop active bleeding in areas like the arms, legs, belly, or chest. It may help people with uncontrolled bleeding that needs to be blocked quickly.
Dallas, TexasAges 22 years+ - NCT06580509RecruitingEarly Phase 1
Spray medicine for bleeding after tonsil removal in children
This study tests if a sprayed form of the medicine tranexamic acid (which helps blood clot) can stop bleeding after tonsillectomy in children. It is for children ages 2 to 17 who come to the emergency room with bleeding that starts more than a day after surgery.
San Antonio, TexasAges 2–17 - NCT06402968Recruiting
Clevidipine for treating high blood pressure after a brain bleed
This trial tests a blood pressure medicine called clevidipine given through an IV to people with a brain bleed (intracerebral hemorrhage). The goal is to see if quickly lowering blood pressure helps prevent more bleeding and improve recovery.
San Antonio, TexasAges 18–100 - NCT06370520Recruiting
Teen emotions screening after mild brain injury
This study screens teens aged 11 to 17 for emotional and mental health problems after a mild traumatic brain injury (mTBI, also called concussion or minor head injury). The goal is to find out if the hospital screening helps identify teens who may need extra support.
Houston, TexasAges 11–17 - NCT06070350RecruitingPhase 3
Massive transfusion for life-threatening bleeding in children
This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).
Houston, TexasAges Up to 17 years - NCT05053867RecruitingPhase 3
Inhaled drug to treat lung bleeding in ventilated cancer patients
This Phase 3 study tests whether inhaled tranexamic acid can reduce lung bleeding (pulmonary hemorrhage) in people with cancer who are on a breathing machine. If you qualify, you may receive the study drug to help stop bleeding in the lungs.
Houston, TexasAges 18 years+ - NCT04916210Recruiting
Study how stroke type affects thinking and recovery
This study looks at what predicts memory and thinking problems after different types of stroke or brain bleeding, and how blood-vessel changes relate to recovery. You may be invited if you recently had a stroke/bleed and can complete a baseline check within 6 weeks.
Houston, TexasAges 18 years+ - NCT04494295Recruiting
Minimally invasive surgery registry for bleeding in the brain
This study records and compares outcomes for people with a specific kind of sudden brain bleeding (intracerebral hemorrhage) using minimally invasive surgery. It may help doctors understand which patients benefit most and improve future care decisions.
Houston, TexasAges 18 years+ - NCT07639853Enrolling by invitation
Doctor feedback survey on Concerto Versa coils
This study gathers feedback from doctors who use Concerto Versa detachable coils (small metal devices that help treat brain aneurysms). The survey helps improve how these coils work and are used.
El Paso, TexasAges 22 years+ - NCT07565753RecruitingEarly Phase 1
Testing a medication to stop bleeding after tonsil removal
This study tests a medicine called tranexamic acid to help stop bleeding in children who had their tonsils removed and are now bleeding more than a day after surgery. Researchers want to see if this medicine can reduce the amount of bleeding and help children recover faster.
San Antonio, TexasAges 2–17 - NCT07260916Recruiting
Minimally invasive brain surgery for large hemorrhages
This trial tests a minimally invasive surgery to remove large, spontaneous brain hemorrhages soon after they occur. The goal is to see if this quick, targeted procedure can improve recovery compared with standard care.
Houston, TexasAges 18–80 - NCT07143019Recruiting
A new device for treating wide-necked brain aneurysms
This trial tests a special device (p48/64 MW HPC) to treat certain brain aneurysms that are wide-necked or have a shape that makes them hard to treat. It might help people with aneurysms that haven't ruptured or that have been treated before and are now coming back.
Dallas, TexasAges 18 years+ - NCT06893588Recruiting
NeVa VS for cerebral vasospasm after brain bleed
This trial is for people who have had a brain bleed from a burst aneurysm and then developed tightening of the brain's blood vessels (vasospasm). It studies how well the NeVa VS device works to open up those narrowed vessels.
Harlingen, TexasAges 22 years+ - NCT05849077Recruiting
Testing oxygen saturation targets during newborn resuscitation
This study looks at the best oxygen saturation targets and resuscitation approach for very premature babies right after birth. It may help clinicians guide breathing support more safely in the first minutes of life.
Dallas, TexasAges birth–10 minutes - NCT06531642RecruitingPhase 2/Phase 3
Early acid-reducing drug for kidney injury after severe bleeding
This study tests whether giving a common acid-reducing medication (a proton pump inhibitor, or PPI) early after severe bleeding from trauma can help protect the kidneys from injury. It compares this early treatment to usual care.
Houston, TexasAges 18 years+ - NCT06286800Recruiting
Personalized brain stimulation for stroke recovery
This study tests a personalized, non-invasive brain stimulation treatment called transcranial direct current stimulation (tDCS) to help improve movement in people who have had a stroke that affects one side of the body. It aims to see if this gentle electrical stimulation can boost recovery of arm and hand function.
Houston, TexasAges 18–80 - NCT06259292Recruiting
HHT patient registry tracking long-term outcomes
This registry collects health information from people with HHT over time to better understand the disease and improve care. Joining does not involve any experimental treatment, but your data will help researchers learn more about HHT.
Dallas, TexasAges Any age - NCT05958342RecruitingPhase 2
Calcium and vasopressin for bleeding shock after major injury
This trial tests whether giving calcium and vasopressin early can improve outcomes in people with major injury who are at risk for life-threatening bleeding shock. It mainly includes patients who need rapid blood transfusion and likely major surgery to stop bleeding.
Lubbock, TexasAges 18–90
Where these studies are running in Texas
Institutions with a site for the recruiting hemorrhage studies listed above.
- University of Texas Southwestern Medical Center · 7 studies
- Memorial Hermann Hospital · 4 studies
- Houston Methodist Hospital · 3 studies
- The University of Texas Health Science Center at Houston · 3 studies
- Memorial Hermann Memorial City Medical Center · 2 studies
- University Hospital · 2 studies
- University of Texas Health Science Center at San Antonio · 2 studies
- University of Texas Medical Branch · 2 studies
What taking part in a hemorrhage study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Hemorrhage trials in other states
Common questions
- Are there hemorrhage clinical trials in Texas?
- Yes. We're currently tracking 29 recruiting hemorrhage studies with a site in Texas, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hemorrhage study in Texas?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Texas to take part?
- Not necessarily. These studies have a site in Texas, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hemorrhage trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hemorrhage studies open in Texas regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.